中文

U.S. Stocks · Health Care · Free Data Page

Guardant Health, Inc. GH

Guardant Health, Inc.: FY2025 revenue $982.0M (+32.90% YoY); net income -$416.3M; 4 alerts, 1 watch item out of 17 risk checks.
Close Price$158.79Day +5.25%Market Cap$21.48BP/E—Negative earnings

Prices are closing data as of 2026-11-09, not real-time quotes. Metric definitions: P/E, P/B, ROE.

Want the full AI research report for Guardant Health, Inc.?

This free page compiles public filings, financial ratios and risk screening. Generate a full research report to add business moat & competition, valuation scenarios, catalysts and bull/bear cases right at this URL.

New users who sign up free and verify their email receive 2 free credits for research reports or professional valuation.

10-Year FinancialsFY2016–2025

Key Multi-Year Facts

  • Revenue moved from $25.2M in FY2016 to $982.0M in FY2025 (9-year CAGR +50.2%).
  • Net income was negative in FY2016, FY2017, FY2018, FY2019, FY2020, FY2021, FY2022, FY2023, FY2024, FY2025.

Latest 5 Fiscal Years

Fiscal Year20212022202320242025
Revenue (USD B)0.370.450.560.740.98
YoY30.3%20.3%25.5%31.0%32.9%
Net Income (USD B)-0.38-0.65-0.48-0.44-0.42
Operating Cash Flow (USD B)-0.21-0.31-0.32-0.24-0.18
ROE-39.6%-185.7%-438.1%——
Gross Margin——59.7%60.8%64.5%
Net Margin-103.0%-145.6%-85.0%-59.1%-42.4%
Debt-to-Assets70.7%96.3%91.1%109.4%104.9%
Show all 10 fiscal years
Fiscal Year2016201720182019202020212022202320242025
Revenue (USD B)0.030.050.090.210.290.370.450.560.740.98
YoY—97.4%81.9%136.5%33.8%30.3%20.3%25.5%31.0%32.9%
Net Income (USD B)-0.05-0.08-0.09-0.08-0.25-0.38-0.65-0.48-0.44-0.42
Operating Cash Flow (USD B)-0.04-0.07-0.07-0.05-0.10-0.21-0.31-0.32-0.24-0.18
ROE-57.9%-42.9%-21.5%-11.8%-24.2%-39.6%-185.7%-438.1%——
Gross Margin———————59.7%60.8%64.5%
Net Margin-182.7%-167.0%-93.8%-35.3%-88.5%-103.0%-145.6%-85.0%-59.1%-42.4%
Debt-to-Assets—10.0%10.6%11.9%40.3%70.7%96.3%91.1%109.4%104.9%

Fiscal years follow the period-end calendar year (hover headers for period-end dates). ROE uses average beginning/ending equity. Source: SEC XBRL filings, compiled mechanically without AI. Official filings

Risk ChecklistAs of 2026-11-10

Rules-based screening using SEC XBRL financial data and 8-K/NT material event filings (no AI opinions).

4Alert 1Watch 9Pass 3N/A

Items Flagged for Review

  • Alert

    Debt-to-Assets RatioSolvency

    114.6%

    Quarterly (2026-09-30) · What is this?

  • Alert

    Interest CoverageSolvency

    Negative (negative EBIT)

    FY2025 (ended 2025-12-31) · What is this?

  • Alert

    Net LossesGoing Concern

    FY2025 (2025-12-31) $-0.42B, FY2024 (2024-12-31) $-0.44B

    FY2025 (ended 2025-12-31)

  • Alert

    Shareholders' EquityGoing Concern

    Shareholders' equity $-0.28B, Retained earnings $-3.35B

    Quarterly (2026-09-30) · What is this?

  • Watch

    High Cash & High DebtSolvency

    cash 54.5% of assets, total debt 79.7% of assets

    Quarterly (2026-09-30)

An "Alert" or "Watch" item flags a number that merits verification in primary filings, not a sell signal.

More U.S. data: 500 largest U.S. companies · U.S. high dividend stocks · Is the stock market open today?

Compiled mechanically from public filings and market quotes (data as of 2026-11-10). For informational purposes only, not investment advice.